| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
1,348 |
1,011 |
$562K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
10,294 |
7,032 |
$323K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,062 |
5,437 |
$302K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,432 |
824 |
$218K |
| 92134 |
|
13,398 |
9,860 |
$169K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
534 |
382 |
$140K |
| J9035 |
Injection, bevacizumab, 10 mg |
3,026 |
2,029 |
$127K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
879 |
784 |
$65K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,523 |
1,338 |
$59K |
| 67228 |
|
196 |
140 |
$49K |
| 92060 |
|
1,162 |
1,082 |
$48K |
| 92136 |
|
2,059 |
1,698 |
$33K |
| 92235 |
|
732 |
658 |
$29K |
| J3590 |
Unclassified biologics |
2,737 |
2,060 |
$24K |
| 92015 |
Determination of refractive state |
1,882 |
1,767 |
$20K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
644 |
569 |
$17K |
| 92250 |
|
828 |
748 |
$17K |
| 92225 |
|
247 |
216 |
$3K |
| 83861 |
|
419 |
224 |
$2K |
| 92202 |
|
131 |
122 |
$947.25 |
| 92273 |
|
29 |
25 |
$885.10 |
| 92133 |
|
51 |
48 |
$522.10 |
| 66821 |
|
19 |
12 |
$98.18 |